The text discusses the use of fluoropyrimidines and oxaliplatin in chemotherapy for colon cancer, recommends genotyping the DPYD gene for abnormal DPD phenotype, and encourages moderate physical activity for patients. Clinical trials PRODIGE 50 and PRODIGE 70 are also mentioned.